Recombinant IgA production for mucosal passive immunization, advancing beyond the hurdles

Area of Science:

• Immunology
• Biotechnology
• Vaccinology

Background:

• Most vaccines do not induce immunity at mucosal surfaces, the primary entry point for pathogens.
• Secretory IgA (SIgA) is crucial for mucosal defense, neutralizing pathogens.
• Mucosal passive immunization using SIgA is a potential alternative for protection.

Purpose of the Study:

• To review manufacturing challenges associated with secretory IgA (SIgA) production.
• To explore innovative solutions for recombinant SIgA production.
• To discuss SIgA manufacturing in mammalian and plant expression systems.

Main Methods:

• Review of existing literature on SIgA structure and production.
• Analysis of difficulties in obtaining SIgA from natural sources.
• Examination of recombinant SIgA production strategies.

Main Results:

• SIgA's complex structure presents significant manufacturing hurdles.
• Recombinant production is challenging but offers potential solutions.
• Mammalian and plant-based systems are being explored for SIgA synthesis.

Conclusions:

• Overcoming SIgA production challenges is key to advancing mucosal passive immunization.
• Innovative biotechnological approaches are vital for scalable SIgA manufacturing.
• Further research into expression systems could yield effective mucosal protection strategies.